IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 318 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $15,348 | -2.5% | 322 | -11.3% | 0.00% | – |
Q1 2024 | $15,735 | +7.6% | 363 | +25.6% | 0.00% | – |
Q4 2023 | $14,621 | +62.0% | 289 | +45.2% | 0.00% | – |
Q3 2023 | $9,027 | +10.6% | 199 | 0.0% | 0.00% | – |
Q2 2023 | $8,165 | +135.5% | 199 | +105.2% | 0.00% | – |
Q1 2023 | $3,467 | +9023.7% | 97 | +9600.0% | 0.00% | – |
Q4 2022 | $38 | – | 1 | 0.0% | 0.00% | – |
Q3 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
Q2 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
Q1 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
Q4 2021 | $0 | – | 1 | -92.9% | 0.00% | – |
Q3 2021 | $0 | – | 14 | +1300.0% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 1 | -98.4% | 0.00% | – |
Q1 2021 | $3,000 | -25.0% | 63 | 0.0% | 0.00% | – |
Q4 2020 | $4,000 | – | 63 | +6200.0% | 0.00% | – |
Q3 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
Q2 2020 | $0 | – | 1 | 0.0% | 0.00% | – |
Q1 2020 | $0 | -100.0% | 1 | -99.7% | 0.00% | – |
Q4 2019 | $21,000 | +40.0% | 351 | +42.7% | 0.00% | – |
Q3 2019 | $15,000 | -6.2% | 246 | 0.0% | 0.00% | – |
Q2 2019 | $16,000 | -20.0% | 246 | +0.4% | 0.00% | – |
Q1 2019 | $20,000 | -41.2% | 245 | -61.6% | 0.00% | -100.0% |
Q4 2018 | $34,000 | +161.5% | 638 | +159.3% | 0.00% | – |
Q3 2018 | $13,000 | -59.4% | 246 | -67.9% | 0.00% | -100.0% |
Q2 2018 | $32,000 | -44.8% | 766 | -42.2% | 0.00% | 0.0% |
Q1 2018 | $58,000 | -6.5% | 1,325 | +7.7% | 0.00% | 0.0% |
Q4 2017 | $62,000 | 0.0% | 1,230 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $62,000 | +10.7% | 1,230 | +11.8% | 0.00% | 0.0% |
Q2 2017 | $56,000 | +1766.7% | 1,100 | +1386.5% | 0.00% | – |
Q1 2017 | $3,000 | -40.0% | 74 | -26.0% | 0.00% | – |
Q4 2016 | $5,000 | +25.0% | 100 | 0.0% | 0.00% | – |
Q3 2016 | $4,000 | +100.0% | 100 | 0.0% | 0.00% | – |
Q2 2016 | $2,000 | -66.7% | 100 | 0.0% | 0.00% | – |
Q4 2015 | $6,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bellevue Group AG | 9,347,926 | $313,529,000 | 3.18% |
Sicart Associates LLC | 291,254 | $9,769,000 | 2.66% |
Camber Capital Management LP | 2,500,000 | $83,850,000 | 2.58% |
SECTOR GAMMA AS | 263,870 | $8,850,000 | 1.76% |
Parkman Healthcare Partners LLC | 136,380 | $4,574,000 | 1.16% |
Eversept Partners, LP | 450,501 | $15,109,804 | 1.05% |
SPHERA FUNDS MANAGEMENT LTD. | 350,000 | $11,739,000 | 0.99% |
TANAKA CAPITAL MANAGEMENT INC | 16,661 | $559,000 | 0.80% |
Sonora Investment Management, LLC | 163,703 | $5,491,000 | 0.69% |
ARK Investment Management | 8,511,384 | $285,472,000 | 0.69% |